New wound matrix shows promise for diabetic foot ulcers
Disease control
Completed
This study tested a skin substitute called Restrata Wound Matrix on 30 adults with diabetic foot ulcers. The goal was to see how well it helped wounds close and to check for safety over 14 weeks. Results may guide future research on this treatment.
Phase: NA • Sponsor: Acera Surgical, Inc. • Aim: Disease control
Last updated May 01, 2026 15:56 UTC